Intern. Med. volume 35, issue 1, P70-73 1996 DOI: 10.2169/internalmedicine.35.70 View full text
|
|
Share
Masaharu KASAI

Abstract: High-dose myelo-ablative therapy in conjunction with autologous bone marrow transplantation (ABMT) has become widely used in patients with leukemias and drug-sensitive solid tumors such as lymphoma, germ cell tumor (GCT), breast cancer, neuroblastoma, sarcoma and so on, demonstrating that ablative therapy has a greater anti-tumor effect than conventional chemotherapy and shows a substantially low relapse rate. Recent apheresis technique using cytokines such as granulocyte